Citadel Advisors’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-241,209
Closed -$4.79M 5768
2025
Q1
$4.79M Buy
241,209
+82,775
+52% +$1.64M ﹤0.01% 1798
2024
Q4
$2.72M Buy
+158,434
New +$2.72M ﹤0.01% 2294
2024
Q3
Sell
-30,351
Closed -$339K 5723
2024
Q2
$339K Sell
30,351
-264,338
-90% -$2.96M ﹤0.01% 4195
2024
Q1
$1.94M Buy
294,689
+59,931
+26% +$396K ﹤0.01% 2517
2023
Q4
$1.06M Sell
234,758
-632,585
-73% -$2.86M ﹤0.01% 2968
2023
Q3
$3.11M Buy
867,343
+812,084
+1,470% +$2.91M ﹤0.01% 1996
2023
Q2
$204K Sell
55,259
-187,437
-77% -$692K ﹤0.01% 4446
2023
Q1
$803K Buy
242,696
+90,076
+59% +$298K ﹤0.01% 3401
2022
Q4
$592K Sell
152,620
-210,137
-58% -$815K ﹤0.01% 3699
2022
Q3
$882K Buy
362,757
+201,530
+125% +$490K ﹤0.01% 3530
2022
Q2
$319K Sell
161,227
-76,419
-32% -$151K ﹤0.01% 4575
2022
Q1
$435K Sell
237,646
-380,603
-62% -$697K ﹤0.01% 4581
2021
Q4
$872K Buy
618,249
+461,861
+295% +$651K ﹤0.01% 3988
2021
Q3
$177K Buy
156,388
+28,373
+22% +$32.1K ﹤0.01% 5505
2021
Q2
$205K Sell
128,015
-92,447
-42% -$148K ﹤0.01% 5553
2021
Q1
$388K Buy
220,462
+69,683
+46% +$123K ﹤0.01% 4799
2020
Q4
$294K Buy
+150,779
New +$294K ﹤0.01% 4251
2020
Q3
Sell
-145,067
Closed -$425K 4619
2020
Q2
$425K Buy
145,067
+106,588
+277% +$312K ﹤0.01% 3568
2020
Q1
$111K Sell
38,479
-3,428
-8% -$9.89K ﹤0.01% 4319
2019
Q4
$168K Sell
41,907
-6,904
-14% -$27.7K ﹤0.01% 4175
2019
Q3
$217K Buy
48,811
+26,624
+120% +$118K ﹤0.01% 4090
2019
Q2
$86K Buy
+22,187
New +$86K ﹤0.01% 4280
2019
Q1
Hold
0
4482
2018
Q2
Sell
-12,890
Closed -$59K 4124
2018
Q1
$59K Buy
+12,890
New +$59K ﹤0.01% 3721